Evidence map›Paper›PMID 26274054›Full record

ArticleInternational journal of circumpolar health2015

Fatty acids linked to cardiovascular mortality are associated with risk factors.

Sven O E Ebbesson, Venkata S Voruganti, Paul B Higgins, Richard R Fabsitz, Lars O Ebbesson, Sandra Laston, William S Harris, John Kennish, Benjamin D Umans, Hong Wang and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of circumpolar health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Red blood cell fatty acid patterns from 7 countries: Focus on the Omega-3 index.Prostaglandins, leukotrienes, and essential fatty acids · 2022
    Article
  11. Article
  12. Article
  13. Drug design, development and therapy · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 3 countries.

Sven O E EbbessonDepartment of Neurological Surgery, University of Virginia, Charlottesville, VA, USA.
Venkata S VorugantiDepartment of Nutrition and UNC Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, NC, USA.
Paul B HigginsKunming Biomed International, Yunnan, China.
Richard R FabsitzNational Heart, Lung, and Blood Institute, Bethesda, MD, USA.
Lars O EbbessonUni Targeting Research AS, Bergen, Norway.
Sandra LastonTexas Biomedical Research Institute, San Antonio, TX, USA.
William S HarrisDepartment of Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA.
John KennishDepartment of Chemistry, University of Alaska Anchorage, Anchorage, AK, USA.
Benjamin D UmansDepartment of Statistics, University of Oxford, Oxford, UK.
Hong WangMedStar Health Research Institute, Hyattsville, MD, USA.
Richard B DevereuxWeill Cornell Medical College, New York, NY, USA.
Peter M OkinWeill Cornell Medical College, New York, NY, USA.
Neil J WeissmanMedStar Health Research Institute, Hyattsville, MD, USA.
Jean W MacCluerTexas Biomedical Research Institute, San Antonio, TX, USA.
Jason G UmansMedStar Health Research Institute, Hyattsville, MD, USA.
Barbara V HowardMedStar Health Research Institute, Hyattsville, MD, USA.
MedStar Health · USCornell University · USTexas Biomedical Research Institute · USGeorgetown-Howard Universities Center for Clinical and Translational Science · USMedical Diagnostic Laboratories (United States) · USNational Heart Lung and Blood Institute · USNeurological Surgery · USUni Research (Norway) · NOUniversity of Alaska Anchorage · USUniversity of North Carolina at Chapel Hill · USUniversity of Oxford · GB

Funding

Georgetown-Howard Universities Center for Clinical and Translational Science (GHUUL1TR000101 · NCATS · GEORGETOWN UNIVERSITY · PI MELLMAN, THOMAS A, VERBALIS, JOSEPH G · 2012 to 2015
$19.3M
Rac-1 mediated superoxide signaling in neuronsU54NS041069 · NINDS · UNIVERSITY OF ALASKA FAIRBANKS · PI DUFFY, LAWRENCE K · 2000 to 2011
$14.1M
Genetics of Coronary Artery Disease in Alaska Natives (*U01HL082490 · NHLBI · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI COMUZZIE, ANTHONY G. · 2005 to 2009
$3.3M
Genetics of Coronary Artery Disease in Alaska NativesU01HL082458 · NHLBI · NORTON SOUND HEALTH CORPORATION · PI EBBESSON, SVEN O · 2005 to 2009
$1.9M
NCATS NIH HHS UL1 TR000101NHLBI NIH HHS R01-HL64244NHLBI NIH HHS U01 HL082458NHLBI NIH HHS U01 HL082490NINDS NIH HHS 2U54-NS041069
6 · The paper itself

Abstract

backgroundAlthough saturated fatty acids (FAs) have been linked to cardiovascular mortality, it is not clear whether this outcome is attributable solely to their effects on low-density lipoprotein cholesterol (LDL-C) or whether other risk factors are also associated with FAs. The Western Alaskan Native population, with its rapidly changing lifestyles, shift in diet from unsaturated to saturated fatty acids and dramatic increase in cardiovascular disease (CVD), presents an opportunity to elucidate any associations between specific FAs and known CVD risk factors.

objectiveWe tested the hypothesis that the specific FAs previously identified as related to CVD mortality are also associated with individual CVD risk factors.

methodsIn this community-based, cross-sectional study, relative proportions of FAs in plasma and red blood cell membranes were compared with CVD risk factors in a sample of 758 men and women aged ≥35 years. Linear regression analyses were used to analyze relations between specific FAs and CVD risk factors (LDL-C, high-density lipoprotein cholesterol, triglycerides, C-reactive protein, systolic blood pressure, diastolic blood pressure, heart rate, body mass index, fasting glucose and fasting insulin, 2-hour glucose and 2-hour insulin).

resultsThe specific saturated FAs previously identified as related to CVD mortality, the palmitic and myristic acids, were adversely associated with most CVD risk factors, whereas unsaturated linoleic acid (18:2n-6) and the marine n-3 FAs were not associated or were beneficially associated with CVD risk factors.

conclusionsThe results suggest that CVD risk factors are more extensively affected by individual FAs than hitherto recognized, and that risk for CVD, MI and stroke can be reduced by reducing the intake of palmitate, myristic acid and simple carbohydrates and improved by greater intake of linoleic acid and marine n-3 FAs.

Indexed as

Cause of DeathAdultAgedAlaskaArctic RegionsCardiovascular DiseasesConfidence IntervalsCross-Sectional StudiesDietary FatsFatty AcidsFeeding BehaviorFemaleHumansLinear ModelsMaleMiddle AgedDietary FatsFatty AcidsAlaska Nativescardiovascular risk factorsdietary fat consumptionfatty acidsfish oil consumptionInuitsaturated fatty acids

Identifiers

PMID26274054
PMCPMC4536775
OpenAlexW1555620591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.